Examining Critical Gaps in AF Stroke Prevention – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Alexander Benz et al, adding:
“Antithrombotic Therapy in Patients with Atrial Fibrillation: Unresolved Issues and Future Directions
This review examines critical gaps in AF stroke prevention, including limitations of current risk scores, populations where vitamin K antagonists remain preferred, uncertain net benefit in special groups, and the emerging promise of factor XI inhibitors for safer anticoagulation.”
Title: Antithrombotic therapy in patients with atrial fibrillation: unresolved issues and future directions
Authors: Alexander Benz, Stephanie Carlin, John Eikelboom
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t